ABG Analytics logo
Get updates

Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 07/19/2019
Closing price: 231.27
Support price level: $221.85
Resistance price level: $239.37
Relative strength index (14-day RSI) 45.4
Beta 1.21
  • With a -35.5 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.

  • BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 35.8%.

  • Volatility is forecast to fall over the next month.

Low High Price as % of Range
$216.71 $383.83 11.4%
200 day 50 day 20 day 10 day
$283.86 $230.91 $234.50 $231.86
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
37.2% 35.7% 35.8% 37.0%
There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than:
  • 9.7% in the next week.

  • 20.9% in the next month.

  • 79.0% in the next year.